The Macrophage in Cardiac Homeostasis and Disease: JACC Macrophage in CVD Series (Part 4).
The Macrophage in Cardiac Homeostasis and Disease: JACC Macrophage in CVD Series (Part 4).
复制标题
DOI:
10.1016/j.jacc.2018.08.2149
复制
发表时间:
2018-10-30
影响因子:
24
通讯作者:
Kovacic JC
中科院分区:
文献类型:
--
作者:
Lavine KJ;Pinto AR;Epelman S;Kopecky BJ;Clemente-Casares X;Godwin J;Rosenthal N;Kovacic JC
Macrophages are integral components of cardiac tissue and exert profound effects on the healthy and diseased heart. Paradigm shifting studies employing advanced molecular techniques have revealed significant complexity within these macrophage populations that reside in the heart. In this final of a 4-part review series covering the macrophage in cardiovascular disease, we review the origins, dynamics, cell surface markers, and respective functions of each cardiac macrophage subset identified to date, including in the specific scenarios of myocarditis and after myocardial infarction. Looking ahead, a deeper understanding of the diverse and often dichotomous functions of cardiac macrophages will be essential for the development of targeted therapies to mitigate injury and orchestrate recovery of the diseased heart. Moreover, as macrophages are critical for cardiac healing, they are an emerging focus for therapeutic strategies aimed at minimizing cardiomyocyte death, ameliorating pathological cardiac remodeling, and for treating heart failure and after myocardial infarction. Macrophages are integral components of cardiac tissue with profound effects on the healthy and diseased heart. Paradigm shifting studies have revealed significant complexity within macrophage populations that reside in the heart. In this final part of a 4-part review series we review the origins, dynamics, cell surface markers, and respective functions of each cardiac macrophage subset identified to date, including in myocarditis and after myocardial infarction. A deeper understanding of the diverse and often dichotomous functions of cardiac macrophages will be essential for the development of targeted therapies to mitigate injury and orchestrate recovery of the diseased heart.
登录
查看更多内容
DOI:
10.1084/jem.20120690
发表时间:
2013-11-18
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Avraham-Davidi I;Yona S;Grunewald M;Landsman L;Cochain C;Silvestre JS;Mizrahi H;Faroja M;Strauss-Ayali D;Mack M;Jung S;Keshet E
通讯作者:
Keshet E
影响因子:
20.1
作者:
DeBerge M;Yeap XY;Dehn S;Zhang S;Grigoryeva L;Misener S;Procissi D;Zhou X;Lee DC;Muller WA;Luo X;Rothlin C;Tabas I;Thorp EB
通讯作者:
Thorp EB
影响因子:
24
作者:
Courties, Gabriel;Heidt, Timo;Sebas, Matthew;Iwamoto, Yoshiko;Jeon, Derrick;Truelove, Jessica;Tricot, Benoit;Wojtkiewicz, Greg;Dutta, Partha;Sager, Hendrik B.;Borodovsky, Anna;Novobrantseva, Tatiana;Klebanov, Boris;Fitzgerald, Kevin;Anderson, Daniel G.;Libby, Peter;Swirski, Filip K.;Weissleder, Ralph;Nahrendorf, Matthias
通讯作者:
Nahrendorf, Matthias
影响因子:
5.5
作者:
Cook, DN
通讯作者:
Cook, DN
影响因子:
4.8
作者:
Dehn,Shirley;Thorp,Edward B.
通讯作者:
Thorp,Edward B.